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ABSTRACT (248 words) 1 
Background: It has been suggested that a higher calcium intake might favorably modify 2 
cardiovascular risk factors. However, findings of an ultimately decreased risk of cardiovascular 3 
disease (CVD) are limited. Instead, recent evidence warns that taking calcium supplements might 4 
increase myocardial infarction (MI) risk. The objective of this study was to prospectively 5 
evaluate the associations of dietary calcium intake and calcium supplementation with MI and 6 
stroke risk and overall CVD mortality.  7 
Methods: Data from 23,980 Heidelberg cohort participants of the European Prospective 8 
Investigation into Cancer and Nutrition study, aged 35-64 years and free of major CVD events at 9 
recruitment, were analyzed. Multivariate Cox regression models were used to estimate hazard 10 
ratios (HRs) and 95% confidence intervals (CIs).  11 
Results: After an average follow-up time of 11 years, 354 MI and 260 stroke cases and 267 12 
CVD deaths were documented. Compared with the lowest quartile, the third quartile of total 13 
dietary and dairy calcium intake had a significantly reduced MI risk, with a HR of 0.69 ( 95% 14 
CI: 0.50, 0.94) and 0.68 (95% CI: 0.50-0.93), respectively. Associations for stroke risk and CVD 15 
mortality were overall null. In comparison to non-users of any supplements, users of calcium 16 
supplements had a statistically significantly increased MI risk (HR: 1.86; 95% CI: 1.17, 2.96), 17 
which was more pronounced for calcium supplement only users (HR: 2.39; 95% CI: 1.12, 5.12).  18 
Conclusions: Increasing calcium intake from diet might not confer significant cardiovascular 19 
benefits, while calcium supplements, which might raise MI risk, should be taken with caution.    20 
 21 
 22 
 23 
 3 
INTRODUCTION 1 
Epidemiological studies have consistently reported inverse associations between dietary calcium 2 
intake and the risk of hypertension, obesity, and type 2 diabetes,[1-8] suggesting that a 3 
reasonably higher intake of this mineral might ultimately decrease the occurrence of 4 
cardiovascular events. Such a plausible health benefit has indeed been observed by several 5 
epidemiological studies. In three prospective studies, dietary calcium intake was significantly 6 
inversely associated with the ischaemic stroke risk.[9-11] A fourth study also found a statistically 7 
significant inverse association between dietary calcium intake and the mortality from ischaemic 8 
heart disease.[12] In a Swedish male cohort, the association between dietary calcium intake and 9 
overall CVD mortality was inverse and of borderline statistical significance.[13] However, 10 
except for these supportive findings, the majority of observational studies reported null 11 
associations.[14-21]  12 
 13 
Calcium supplements, which are commonly recommended to elderly people, particularly 14 
postmenopausal women, to maintain their bone health, have also been suggested as beneficial 15 
agents to improve serum cholesterol profile [22-24] and to control hypertension.[25] However, 16 
no strong epidemiological evidence suggests that calcium supplementation might provide 17 
cardiovascular benefits.[10, 12, 14, 16] Instead, two recent meta-analyses of clinical trials have  18 
prompted a warning that calcium supplements might increase an individual’s risk of having 19 
myocardial infarction (MI).[26, 27]  20 
 21 
 4 
In the present study, we aimed to prospectively examine the associations of dietary calcium 1 
intake, in total or separated as from dairy sources and from non-dairy sources, and calcium 2 
supplementation with MI and stroke risk and overall CVD mortality in a German cohort.  3 
 4 
METHODS 5 
Study population 6 
Heidelberg cohort is one of the two German cohorts participating in the European Prospective 7 
Investigation into Cancer and Nutrition (EPIC) study. In 1994-1998, the EPIC-Heidelberg cohort 8 
recruited 25,540 local residents, who were then aged 35-64 years. A detailed description of the 9 
recruitment procedures has been published elsewhere.[28] The ethics committee of the 10 
Heidelberg University Medical School approved the study protocol and all participants provided 11 
an informed consent. In this study, we excluded participants who had a diagnosis of MI, stroke, 12 
or transient ischaemic attack at baseline (n=1,322). We also excluded participants whose daily 13 
energy intake fell into the top or the bottom 0.5 percentile (men: <887/> 5,582 kcal/day; women: 14 
< 70 / > 4,381 kcal/day; n=257), and eventually had 23,980 participants remained for analysis.  15 
 16 
Assessment of dietary calcium intake and calcium supplementation 17 
A self-administered food frequency questionnaire (FFQ), which had been validated using 12 24-18 
hour dietary recalls in a subsample of 104 participants from the two German cohorts,[29, 30] was 19 
used to assess consumption of 148 food items in the 12 months before the date of recruitment. 20 
Dietary calcium intake was derived using the German Nutrient Database BSL, version II.3. 21 
Within the entire EPIC-Germany, dairy foods and non-alcoholic beverages were the main 22 
sources of dietary calcium, providing 39.9% and 28.2% of the daily intake, respectively.[31] The 23 
 5 
Spearman correlation coefficient between the FFQ and the 12 24-hour dietary recalls was 0.58 1 
for dairy foods and 0.70 for non-alcoholic beverages.[30]  2 
 3 
In a baseline interview and follow-up questionnaire surveys, participants were asked if they had 4 
regularly taken vitamin/mineral supplements in the past 4 weeks, where “regularly” was defined 5 
as daily use for at least 1 week or non-daily use of at least 5 doses on a regular basis. Self-6 
reported supplements were coded using the Anatomical Therapeutic Chemical (ATC) 7 
classification system. Data on dosage were not collected. In this study, we separated cohort 8 
participants into users of calcium supplements (ATC code A12A), users of other supplements 9 
(containing users of unspecified supplements), and non-users of any supplements. Users of 10 
calcium supplements were also separated into calcium supplement only users and users of 11 
calcium supplements plus other vitamins/minerals. 12 
 13 
Ascertainment of cardiovascular outcomes 14 
Incident cardiovascular events during follow-up were reported by participants or their next of kin 15 
in follow-up surveys. Reported cardiovascular events were verified by tracking medical records 16 
or official death certificates. In the present study, cardiovascular events of interest, which were 17 
coded using the International Classification of Diseases 10th version (ICD-10), were incident MI 18 
(ICD-10 codes I21-I23), incident stroke (ICD-10 codes I60-I69), and overall CVD mortality 19 
(ICD-10 codes I00-I99).  20 
 21 
Statistical analysis 22 
 6 
Dietary intakes of calcium and other nutrients were adjusted for total energy intake of 2,200 1 
kcal/day for men and 1,700 kcal/day for women using the residual method.[32] Residuals were 2 
obtained from sex-specific linear regressions of the log-transformed calcium intake on the log-3 
transformed total energy intake. The energy-adjusted calcium intakes were categorized into 4 
quartiles using sex-specific cut-off points. The lowest quartiles were used as reference groups. 5 
 6 
Age- and sex-adjusted baseline characteristics of participants across quartiles of energy-adjusted 7 
total dietary calcium intake and across calcium supplementation status were compared using 8 
analysis of covariance for continuous variables and logistic regression for binary variables.[33] 9 
Multivariate Cox regressions were performed to estimate hazard ratios (HRs) and 95% 10 
confidence intervals (CIs). To avoid violation of the proportionality assumption, all models were 11 
stratified by the rounded age at recruitment (1-year category). The following potential 12 
confounders were adjusted for in the analyses of dietary calcium intake: sex, age at recruitment, 13 
the highest educational level (no/primary school, secondary/technical school, and university), 14 
physical activity (inactive, moderately inactive, moderately active, and active), body mass index 15 
(BMI, kg/m2), smoking categories (never smoker; former smoker, quit ≥10 years and quit <10 16 
years; current smoker, ≤10, 11-20, and >20 cigarettes/day), lifetime alcohol intake (g/day), total 17 
energy intake (kcal/day), energy-adjusted dietary intakes of vitamin D (µg/day), saturated fatty 18 
acids (g/day), and total protein (g/day), self-reported diabetes mellitus at recruitment, and use of 19 
calcium supplements. Other baseline characteristics, including dietary intakes of fiber, vitamin 20 
C, and folic acid, self-reported hypertension, hyperlipidemia, and regular use of antihypertensive 21 
drugs, lipid-lowering drugs, and non-steroidal anti-inflammatory drugs (NSAIDS) only slightly 22 
affected the HRs, and therefore they were not included into the final models. Dairy and non-23 
 7 
dairy calcium intakes were mutually adjusted for when they were analyzed separately. Linear 1 
trends were examined using the likelihood ratio test, in which the median intakes of quartiles 2 
were modeled as a continuous variable.  3 
 4 
Multivariate Cox models that examined the effects of calcium supplementation also adjusted for 5 
total dietary calcium intake, self-reported hyperlipidemia, and use of NSAIDs, as they 6 
appreciably affected the risk estimates. In addition to examining the effect of calcium 7 
supplementation at baseline, extended Cox regression models [34] were fitted to examine the 8 
effects of the most recent and the cumulative calcium supplementation by using the data on 9 
supplement use collected during the follow-up. All analyses were repeated after exclusion of 10 
CVD events that occurred in the first 2 years of follow-up.  11 
 12 
All statistical tests were two-sided, with P <0.05 being considered statistically significant. SAS 13 
software (version 9.2; SAS Institute, Cary, NC) was used to perform all statistical analyses.  14 
 15 
RESULTS 16 
Table 1 shows the baseline characteristics of participants by quartiles of the energy-adjusted total 17 
dietary calcium intake and by calcium supplementation status. A higher dietary calcium intake 18 
was mainly associated with favorable factors, including younger age, higher likelihood of having 19 
a university degree and being physically active, less likelihood of being overweight/obese (BMI 20 
≥ 25 kg/m2) and current smokers, and an averagely shorter smoking duration and lower lifestyle 21 
alcohol consumption. Dietary calcium intake was also positively associated with dietary vitamin 22 
D and saturated fatty acid intake and the likelihood of taking calcium supplements. Compared 23 
 8 
with non-users, users of calcium supplements were more likely to be women, physically more 1 
active, and less likely to be overweight/obese. On the other hand, users of calcium supplements 2 
had an older age, an overall lower educational level, and a longer duration of smoking.      3 
 4 
After an average follow-up time of 11 years, 354 MI cases, 260 stroke cases, and 267 CVD 5 
deaths were documented. After adjustment for potential confounders, a statistically significant 6 
inverse association was only observed between total dietary calcium intake and MI risk for the 7 
third quartile compared with the lowest quartile (HR: 0.69; 95% CI: 0.50, 0.94; Table 2). 8 
Compared with the lowest quartile, the second quartile of total calcium intake had a statistically 9 
significantly increased stroke risk (1.50; 95% CI: 1.06, 2.11), which became non-significant after 10 
exclusion of the first 2 years of follow-up. For source-specific calcium intake, the previously 11 
observed reduction of MI risk in the third quartile of total calcium intake remained in the third 12 
quartile of dairy calcium intake (HR: 0.68; 95% CI: 0.50, 0.93; Table 3). None of the linear trend 13 
tests was statistically significant. Further exclusion of supplement users from analyses did not 14 
substantially change the risk estimates for total and source-specific dietary calcium intakes.  15 
 16 
As shown in Table 4, users of calcium supplements had a statistically significantly increased MI 17 
risk when compared with non-users of any supplements (HR: 1.86; 95% CI: 1.17, 2.96). This 18 
association was more pronounced for calcium supplement only users (HR: 2.39; 95% CI: 1.12, 19 
5.12) and persisted after MI cases that occurred in the first 2 years of follow-up were excluded 20 
(HR: 2.70; 95% CI: 1.26, 5.79). As shown in the extended Cox regression models, the most 21 
recent but not the cumulative calcium only supplementation was significantly inversely 22 
 9 
associated with MI risk (HR: 2.17; 95% CI: 1.06, 4.42). No statistically significant association 1 
was observed between calcium supplementation and either stroke risk or overall CVD mortality.  2 
 3 
DISCUSSION 4 
In this prospective cohort study, total, dairy, or non-dairy calcium intake did not manifest an 5 
overall statistically significant inverse association with cardiovascular risk, except for a likely 6 
reduction of MI risk associated with a moderately higher dairy calcium intake. However, this 7 
study also suggests that MI risk might be substantially increased by taking calcium supplements.   8 
 9 
The association between dietary calcium intake and MI risk has been rarely reported. In our 10 
cohort, a moderately higher dietary calcium intake (the third quartile, mean=820 mg/day) was 11 
statistically significantly associated with a 30% lower MI risk. However, this inverse association 12 
became non-significant for men (HR: 0.80; 95% CI: 0.56, 1.14) but more significant for women 13 
(HR: 0.43; 95% CI: 0.22, 0.82). A possible explanation to this gender-related disparity might be, 14 
if we assume the observed inverse association were false, that a higher dietary calcium intake 15 
was associated with certain unadjusted confounders in women but not in men. In a cohort study 16 
of middle-aged and elderly US male health professionals, which has perhaps been the only large-17 
scale study reporting this association so far, no significant results were found, even in 18 
participants who had similar calcium intakes for which the association was statistically 19 
significant in the present study.[14] In addition to inclusion of only men, the US study used the 20 
standard method, whereas we used the residual method, to adjust for total energy intake. It has 21 
been noted that these two methods might generate substantially different results if nutrient 22 
variables were categorized into quantiles.[35] In our cohort, the inverse association was only 23 
 10 
confined to dairy calcium intake, suggesting a possibility that the inverse association might be 1 
caused by other unknown nutrients coexisting in milk products. For instance, three case-control 2 
studies have reported an inverse association between dairy fat biomarkers (pentadecanoic and 3 
heptadecanoic acid) and the risk of a first-ever MI or cardiovascular risk factors.[36-38]  4 
 5 
Our finding of an overall null association between total, dairy, or non-dairy calcium intake and 6 
stroke risk consists with  the majority of previous findings,[15-17, 21] although two studies of 7 
Japanese/Japanese immigrants and one study of US women observed a statistically significant 8 
inverse association.[9, 10, 39] An easy interpretation to this inverse association is that the 9 
potential anti-hypertensive effect of calcium might cause an ultimate reduction in ischemic 10 
stroke risk. However, none of these three studies reported a similar reduced risk of hemorrhagic 11 
stroke, which is equally likely to be caused by hypertension. In addition, the much lower dietary 12 
calcium intake in two Japanese studies limits its comparability with results from a western 13 
population. A meta-analysis found that a higher consumption of milk, a major dietary source of 14 
calcium in western countries, was statistically significantly associated with a decreased risk of 15 
ischaemic stroke.[40] However, it is hard to conclude that this inverse association is mainly 16 
driven by the calcium content.  17 
 18 
In the present study, no overall statistically significant association was observed between total, 19 
dairy, or non-dairy calcium intake and CVD mortality. This finding is in line with two other 20 
studies.[18, 20] In a third study of Swedish men, the association was almost statistically 21 
significant (HR highest versus lowest tertile: 0.77; 95% CI: 0.58, 1.01; Ptrend=0.06).[13] In 22 
comparison to the studies reporting null associations, including the present study, the Swedish 23 
 11 
study had a significantly higher dietary calcium intake (overall mean=1,400 mg/day; mean for 1 
the highest tertile=1953 mg/day). The effect of dietary calcium intake at such a high level on 2 
CVD mortality, however, might not be possible for many observational studies to investigate.  3 
 4 
We observed a statistically significantly increased MI risk among users of calcium supplements, 5 
in agreement with the results of two meta-analyses of clinical trials.[26, 27] The more 6 
pronounced increase was observed among calcium supplement only users, suggesting that this 7 
adverse effect is mainly from calcium supplements themselves. Unlike the baseline and the most 8 
recent calcium supplementation, the model for cumulative calcium supplementation only yielded 9 
a statistically non-significant inverse association with MI risk. However, it should be noted that 10 
this model was based on a hypothetical linear relationship between times of self-reported 11 
calcium supplementation and MI risk. Therefore, we conclude that for an elderly population, this 12 
adverse effect might not rely much on a very long term of supplementation. So far, only very few 13 
observational studies have reported on the association between calcium supplementation and MI 14 
risk. In the US study of male health professionals, this association was null.[14] In a small 15 
British cohort study of women, calcium plus vitamin D supplementation was also not associated 16 
with MI risk.[41] There has been one study that observed an increased risk of coronary heart 17 
disease among women who took calcium or calcium plus vitamin D supplements.[42] To the 18 
best of our knowledge, the present study is the first observational study to report a possible 19 
adverse effect of calcium supplements on MI risk. With respect to the associations between 20 
calcium supplementation and stroke risk and overall CVD mortality, the present study and all 21 
previous observational studies are in agreement on the null associations.[10, 12, 14, 16]   22 
 23 
 12 
The underlying mechanisms of the adverse effect of calcium supplements on MI risk might be in 1 
relation to the acute increase in serum calcium, which has been observed after ingestion of 2 
calcium supplements, but not after eating calcium-rich foods.[43, 44] Several studies have 3 
observed a positive association between serum calcium levels and vascular calcification.[45, 46] 4 
Too much calcium in serum might cause this pathological change by influencing calcification 5 
modulators such as pyrophosphate and binding to the calcium sensing receptors on vascular 6 
smooth muscle cells.[47] Other studies have reported positive associations of serum calcium 7 
levels with some predictive biomarkers of CVD, such as fasting insulin and lipid measures,[48, 8 
49] and more directly, with MI risk.[50-52] As a key regulator of calcium metabolism, 9 
parathyroid hormone has also shown a close relationship with cardiovascular risk.[53-55] 10 
Therefore, in order to achieve a better understanding of the mechanisms behind the adverse 11 
cardiovascular effect of calcium supplementation, its interactions with of parathyroid hormone 12 
should be investigated.  13 
  14 
The present study has several strengths, such as its prospective design, relatively large sample 15 
size, and an average follow-up time of more than 10 years. However, the present study also has 16 
several important limitations. Firstly, our dietary data suffered from measurement errors, which 17 
are unavoidable in application of a FFQ. In addition, one single measure of dietary nutrient 18 
intakes at baseline apparently could not capture the long-term variation, as we know that 19 
individuals might modify their diet after onset of certain diseases or enhancement of health 20 
consciousness. The same problem also stands for those modifiable lifestyle confounders. 21 
Secondly, the present study only excluded pre-existing MI, stroke, and transient ischaemic 22 
attack. Failing to exclude individuals with other pre-existing CVD subtypes might attenuate an 23 
 13 
inverse association with CVD mortality if they were more likely to have a calcium-rich diet than 1 
relatively healthy individuals, or the other way round. However, the influence of this incomplete 2 
exclusion should be minor, as MI and stroke together account for the vast majority of CVD. 3 
There is also no evidence suggesting that individuals with pre-MI conditions are more likely to 4 
take calcium supplements. On the contrary, the positive association between calcium 5 
supplementation and MI risk was strengthened by exclusion of the first 2-year follow-up. 6 
Thirdly, in most of the clinical trials included in the above-mentioned meta-analyses,[26, 27] 7 
calcium in elemental form was administered at 1,000 mg/day or higher. Therefore, whether a 8 
lower dosage will still pose an extra MI risk should be examined. Unfortunately, the present 9 
study could not answer this question due to lack of detailed data. Lastly, it needs to be noted that 10 
44.5% of vitamin/mineral users in the present study did not report the names of their 11 
supplements, and we therefore only identified a limited number of calcium supplement users, 12 
who accounted for 3.6% of all cohort participants. This prevalence is lower than that observed in 13 
a small German elderly population (about 8% in men and 27% in women).[56] It is also lower 14 
than the prevalence (11.0%) reported by a US national survey.[57] It is possible that the 15 
unreported calcium supplementation would affect the accuracy of our results if identified 16 
calcium supplement users were different from those unidentified ones in cardiovascular risk 17 
profile.     18 
 19 
In conclusion, the present study suggests that increasing dietary calcium intake from diet might 20 
not confer significant cardiovascular benefits, while calcium supplements, which might raise MI 21 
risk, should be taken with caution.    22 
 23 
 14 
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Table 1. Age- and sex-adjusted baseline characteristics of participants by sex-specific quartile of dietary calcium intake and calcium 
supplementation status, the EPIC-Heidelberg cohort, 1994 -1998 
 Total dietary calcium intake  
in quartiles 1 
 
Calcium supplementation 
 1 
(low) 2 3  4 (high) 
 Calcium 
supplements 
Other 
supplements 
Non-use of any 
supplements 
No. of participants 2 5,986 5,993 5,998 6,003  851 7,170 15,959 
Total dietary calcium intake 1 (mg/day)  513 675 820 1130†  828 820 766† 
Dairy calcium intake 1 (mg/day)  188 330 466 780†  477 470 426† 
Non-dairy calcium intake 1 (mg/day)  324 345 353 351†  352 349 340† 
Dietary vitamin D intake 1 (µg/day)  3.0 3.2 3.3 3.4†  3.4 3.4 3.2† 
Dietary intake of saturated fatty acids 1 (g/day)  30.0 30.8 31.3 32.3†  30.6 30.7 31.3† 
Dietary intake of total protein 1 (g/day)  65.2 67.3 69.5 74.5†  70.3 69.2 69.0 
Smoking duration (years) 13.5 11.8 11.5 11.7†  13.0 12.3 12.0† 
Lifetime alcohol intake (g/day) 21.3 17.7 15.2 13.8†  17.3 17.1 17.0 
Age at recruitment (years) 51.2 50.6 50.3 50.5†  53.6 51.8 50.0† 
Women (%) 54.1 54.0 54.2 54.0  72.4 60.9 49.8† 
University degree (%) 21.5 28.6 33.2 38.1†  25.2 33.8 29.1† 
Physically active (%) 22.0 24.1 24.2 29.3†  32.7 25.6 24.2† 
BMI ≥ 25 kg/m2 (%) 57.8 56.9 54.9 53.1†  50.9 51.8 57.6† 
Current smokers (%) 28.8 22.1 20.9 21.5†  23.9 22.1 23.9† 
Hypertension at recruitment 3 (%) 29.2 29.1 27.8 28.2  26.7 28.9 28.6 
Hyperlipidemia at recruitment 3 (%) 35.6 36.7 34.5 35.0  38.8 37.0 34.6† 
Diabetes mellitus at recruitment 3 (%) 3.1 3.5 3.4 4.8†  3.5 3.5 3.8 
Use of anti-hypertensive drugs (%) 13.6 14.7 13.5 14.3  13.8 16.3 13.0† 
Use of lipid-lowering drugs (%) 3.3 3.7 4.0 3.9  4.9 4.4 3.3† 
Use of NSAIDs (%) 6.0 5.5 5.7 6.5  9.6 8.0 4.8† 
Use of calcium supplements (%) 3.1 3.2 3.5 4.4†     
BMI, body mass index; EPIC, European Prospective Investigation into Cancer and Nutrition; NSAIDS, non-steroidal anti-inflammatory 
drugs. 
† P < 0.05. Values are either percentages or means 
1 Adjusted for total energy intake using the residual method. The cut-off points were 603, 748, and 924 mg/day for men, and 610, 738, 
and 898 mg/day for women. 
2 Participants with a diagnosis of MI, stroke, or transient ischaemic attack at recruitment and participants whose total energy intake fell 
into the top or bottom 0.5 sex-specific percentile (men: < 887 / > 5,582 kcal/day; women: < 703 / > 4,381 kcal/day) were excluded. . 
3 Self-reported.   
 21 
Table 2. Multivariate HRs and 95% CIs for MI and stroke incidence and CVD 
mortality by quartile of total dietary calcium intake, the EPIC-Heidelberg cohort, 
1994 - 2010  
 Quartile 
No. of  
cases 
HR and 95% CI 
Model A Model B 
MI incidence 1 (low) 101 1.00 (ref) 1.00 (ref) 
 2 91 0.94 (0.70-1.25) 1.01 (0.75-1.37) 
 3 70 0.69 (0.50-0.94) 0.67 (0.48-0.94) 
     4 (high) 92 0.85 (0.63-1.16) 0.92 (0.66-1.27) 
 Ptrend  0.22 0.39 
Stroke incidence 1 (low) 58 1.00 (ref) 1.00 (ref) 
 2 79 1.50 (1.06-2.11) 1.38 (0.94-2.01) 
 3 64 1.24 (0.86-1.79) 1.28 (0.86-1.89) 
 4 (high) 59 1.12 (0.76-1.65) 1.17 (0.77-1.77) 
 Ptrend  0.97 0.73 
CVD mortality 1 (low) 65 1.00 (ref) 1.00 (ref) 
   2 75 1.34 (0.95-1.88) 1.51 (1.05-2.17) 
 3 61 1.15 (0.80-1.65) 1.22 (0.83-1.81) 
 4 (high) 66 1.18 (0.82-1.72) 1.30 (0.87-1.94) 
 Ptrend  0.62 0.44 
BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease; 
EPIC, European Investigation into Cancer and Nutrition, HR, hazard ratio; MI, 
myocardial infarction.   
Model A: adjusted for sex, age at recruitment, educational level, physical activity, 
BMI, smoking categories, lifetime alcohol intake, energy-adjusted dietary vitamin 
D, saturated fatty acid, and total protein intake, total energy intake, self-reported 
diabetes mellitus at recruitment, and use of calcium supplements. 
Model B: cardiovascular events that occurred in the first 2 years of follow-up 
were excluded. 
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Table 3. Multivariate HRs and 95% CIs for MI and stroke incidence and CVD mortality by 
quartile of dairy and non-dairy calcium intake, the EPIC-Heidelberg cohort, 1994 - 2010  
 Quartile 1  
No. of  
cases 
HR and 95% CI 
Model A Model B 
Dairy calcium     
MI incidence 1 (low) 104 1.00 (ref) 1.00 (ref) 
 2 91 0.91 (0.68-1.21) 0.89 (0.66-1.20) 
 3 71 0.68 (0.50-0.93) 0.64 (0.46-0.90) 
     4 (high) 88 0.77 (0.57-1.05) 0.77 (0.56-1.07) 
 Ptrend  0.07 0.10 
Stroke incidence 1 (low) 71 1.00 (ref) 1.00 (ref) 
 2 66 1.01 (0.72-1.42) 0.97 (0.67-1.40) 
 3 58 0.91 (0.64-1.31) 0.88 (0.60-1.31) 
 4 (high) 65 1.01 (0.70-1.47) 1.04 (0.70-1.55) 
 Ptrend  0.91 0.90 
CVD mortality 1 (low) 70 1.00 (ref) 1.00 (ref) 
   2 65 1.07 (0.76-1.50) 1.17 (0.81-1.69) 
 3 63 1.07 (0.76-1.53) 1.15 (0.78-1.67) 
 4 (high) 69 1.09 (0.76-1.58) 1.16 (0.78-1.72) 
 Ptrend  0.70 0.56 
Non-dairy calcium     
MI incidence 1 (low) 98 1.00 (ref) 1.00 (ref) 
 2 84 0.93 (0.69-1.25) 0.94 (0.68-1.28) 
 3 73 0.85 (0.62-1.16) 0.82 (0.59-1.15) 
     4 (high) 99 1.15 (0.86-1.55) 1.22 (0.90-1.67) 
 Ptrend  0.40 0.24 
Stroke incidence 1 (low) 68 1.00 (ref) 1.00 (ref) 
 2 53 0.84 (0.58-1.20) 0.91 (0.62-1.35) 
 3 61 0.99 (0.70-1.42) 1.01 (0.68-1.49) 
 4 (high) 78 1.26 (0.89-1.77) 1.35 (0.93-1.95) 
 Ptrend  0.08 0.07 
CVD mortality 1 (low) 87 1.00 (ref) 1.00 (ref) 
   2 59 0.77 (0.55-1.08) 0.73 (0.51-1.05) 
 3 58 0.80 (0.57-1.13) 0.82 (0.57-1.17) 
 4 (high) 63 0.89 (0.63-1.25) 0.81 (0.56-1.17) 
 Ptrend  0.53 0.32 
BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease; EPIC, 
European Investigation into Cancer and Nutrition, HR, hazard ratio; MI, myocardial 
infarction.   
Model A: adjusted for sex, age at recruitment, educational level, hysical activity, BMI, 
smoking categories, lifetime alcohol intake, energy-adjusted dietary vitamin D, saturated 
fatty acid, and total protein intake, total energy intake, self-reported diabetes mellitus at 
recruitment, and use of calcium supplements. Dairy calcium intake and non-dairy calcium 
intake were also mutually adjusted for.  
Model B: cardiovascular events that occurred in the first 2 years of follow-up were 
excluded. 
1 For dairy calcium intake, the cut-off points were 236, 372, and 552 mg/day for men and 
283, 410, and 572 mg/day for women. For non-dairy calcium intake, the cut-off points 
were 319, 359, and 404 mg/day for men and 280, 316, and 357 mg/day for women.  
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Table 4. Multivariate HRs and 95% CIs for MI and stroke incidence and CVD mortality by calcium supplementation status, the EPIC-
Heidelberg cohort, 1994 - 2010  
 Supplements  
No. of 
cases 
HR and 95% CI 
Model A Model B Model C Model D 
MI incidence       
 
Non-use of any 
supplements 256 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 Calcium 20 1.86 (1.17-2.96) 1.79 (1.09-2.96) 1.28 (0.89, 1.85) 1.20 (0.93, 1.54) 
     Calcium only 1     7   2.39 (1.12-5.12)   2.70 (1.26-5.79)   2.17 (1.06, 4.42)   1.44 (0.80, 2.61) 
         Calcium plus others 2     13   1.66 (0.95-2.93)   1.45 (0.77-2.75)   1.14 (0.76, 1.72)   1.16 (0.88, 1.52) 
 Other supplements 78 0.75 (0.58-0.97) 0.75 (0.57-0.99) 0.86 (0.67, 1.12) 0.86 (0.72, 1.01) 
Stroke incidence       
 
Non-use of any 
supplements 179 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 Calcium 10 1.05 (0.55-1.99) 1.04 (0.51-2.14) 1.08 (0.69, 1.68) 0.93 (0.66, 1.30) 
     Calcium only 1     1   0.34 (0.05-2.47)   0.43 (0.06-3.08)   0.59 (0.15, 2.41)   0.55 (0.18, 1.68) 
     Calcium plus others 2     9   1.35 (0.69-2.66)   1.31 (0.61-2.82)   1.17 (0.74, 1.86)   1.00 (0.70, 1.43) 
 Others 71 0.87 (0.66-1.16) 0.97 (0.71-1.31) 0.86 (0.64, 1.15) 0.89 (0.74, 1.09) 
CVD mortality       
 
Non-use of any 
supplements 184 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
 Calcium 9 1.02 (0.51-2.00) 1.04 (0.51-2.15) 1.14 (0.76, 1.72) 1.07 (0.82, 1.41) 
     Calcium only 1     3   1.20 (0.38-3.78)   1.39 (0.44-4.39)   1.54 (0.63, 3.78)   1.23 (0.63, 2.40) 
     Calcium plus others 2     6   0.94 (0.41-2.15)   0.91 (0.37-2.24)   1.08 (0.70, 1.69)   1.05 (0.78, 1.41) 
 Other supplements 74 0.94 (0.71-1.24) 0.92 (0.68-1.24) 0.96 (0.72, 1.28) 0.88 (0.74, 1.05) 
BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease; EPIC, European Prospective Investigation into Cancer and 
Nutrition; HR, hazard ratio; MI, myocardial infarction; NSAIDS, non-steroidal anti-inflammatory drugs.  
Model A: adjusted for sex, age at recruitment, educational level, physical activity, BMI, smoking categories, lifetime alcohol intake, 
energy-adjusted total dietary calcium, vitamin D, saturated fatty acid, and total protein intake, total energy intake, and self-reported 
hyperlipidemia and diabetes mellitus at recruitment, and use of NSAIDs.  
Model B: excluded cardiovascular events that occurred in the first 2 years of follow-up. 
Model C: the effects of the most recent supplementation. 
Model D: the effects of the cumulative supplementation. The HRs indicate the relative risks for each self-report of supplementation  
1 n = 256. 
2 n = 695. 
 
